|
| |
| | | 67046 | | 11.08.2020 | | Bristol-Myers Squibb SA | | | | | | | | | | | | | 01.99. | | | | 01.99. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Zeposia 0.23 mg | Hartkapseln | Capsules (Ozanimodum 0.23 mg) | L04AE02 | CI | | 02 | Zeposia 0.46 mg | Hartkapseln | Capsules (Ozanimodum 0.46 mg) | L04AE02 | | | 03 | Zeposia 0.92 mg | Hartkapseln | Capsules (Ozanimodum 0.92 mg) | L04AE02 | |
|
|
|
